Prothena Corporation plc (PRTA) vs YD Bio Limited (YDES)

Prothena Corporation plc PRTA 8.48 +0.59%
YD Bio Limited YDES 6.08 −3.95%

Prothena Corporation plc and YD Bio Limited are both Biotechnology companies. Prothena Corporation plc and YD Bio Limited are of similar size ($476.8M and $453.8M).

Metric	PRTA	YDES	Biotechnology median
P/E	n/m	—	8.56
P/S	8.06	—	10.17
P/B	1.53	—	2.34
Price to free cash flow	n/m	—	20.42
EV/EBITDA	n/m	—	0.69
EV/Sales	2.78	—	9.64
Earnings yield	(9.85%)	—	(29.41%)
Free cash flow yield	(13.83%)	—	(23.50%)

Metric	PRTA	YDES	Biotechnology median
Gross margin	100.00%	—	65.16%
Operating margin	(101.80%)	—	0.00%
Net margin	(80.67%)	—	0.00%
Free cash flow margin	(111.49%)	—	0.00%
Return on equity	(14.39%)	—	(56.66%)
Return on assets	(12.54%)	—	(49.22%)
Return on invested capital	0.00%	—	0.00%

Metric	PRTA	YDES	Biotechnology median
Revenue growth (TTM)	427.32%	—	5.64%
EPS growth (last fiscal year)	(99.56%)	—	30.08%
Revenue growth, 5-year CAGR	62.56%	—	9.41%
Net income growth, 5-year CAGR	0.00%	—	0.00%

Metric	PRTA	YDES	Biotechnology median
Debt to equity	0.00	—	0.00
Current ratio	25.05	—	4.72
Net debt to EBITDA	1.46	—	0.96

Metric	PRTA	YDES	Biotechnology median
Dividend yield	—	—	0.08%
Payout ratio	—	—	—

Metric	PRTA	YDES	Biotechnology median
Market cap	453.82m	476.77m	151.40m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack